Featured Research

from universities, journals, and other organizations

Tumor chromosomal translocations reproduced for first time in human cells

Date:
June 3, 2014
Source:
Centro Nacional de Investigaciones Oncologicas (CNIO)
Summary:
chromosomal translocations associated with two types of cancer, acute myeloid leukemia and Ewing's sarcoma, have been reproduced, for the first time in human cells, by scientists. The study's authors conclude by stating that the use of this technology will allow for the clarification of how and why chromosomal translocation occurs, which without doubt will allow new anti-cancer therapeutic strategies to be tackled.

Shown are translocations of chromosomes 11 (green) and 13 (red), implicated in Ewing' sarcoma, obtained using the RGEN genetic tool.
Credit: CNIO

Scientists from the Spanish National Cancer Research Centre (CNIO) and the Spanish National Cardiovascular Research Centre (CNIC) have been able to reproduce, for the first time in human cells, chromosomal translocations associated with two types of cancer: acute myeloid leukemia and Ewing's sarcoma. The discovery, published today in the journal Nature Communications, opens the door to the development of new therapeutic targets to fight these types of cancer.

Related Articles


The study was carried out by Sandra Rodriguez-Perales − from CNIO's Molecular Cytogenetics Group, led by Juan Cruz Cigudosa − and Juan Carlos Ramírez and Raúl Torres, from CNIC's Viral Vector Technical Unit. The researchers have shown that it is possible to produce chromosome modifications in human cells that are genetically identical to those observed in leukemia and other types of human cancer.

This new technology offers two main advantages based on the use of molecular tools to manipulate the genome: firstly, working models that had not existed up until now for the study of tumour biology and, secondly, their application will eventually allow for the study of new therapeutic targets and therapies.

The alterations leading to tumour development are due to multiple changes in cell physiology and specifically in the cell genome. In leukemia and other tumours called sarcomas, exchanges of large DNA fragments occur between different chromosomes, a phenomenon known as chromosomal translocations. As the study's authors point out, these translocations are necessary both for the generation and the progression of a number of neoplastic processes.

"The study of this type of tumours has been problematic up to now due to the lack of cell models and the appropriate animal models," says CNIC researcher Juan Carlos Ramírez, who adds that the difficulty of generating these chromosomal translocations had limited the availability of cells with this mark of the disease.

Breaking chromosomes to study cancer

Using RNA-Guided Endonuclease (RGEN) technology or CRISPR/Cas9 genome engineering technology, CNIO and CNIC researchers have shown that it is possible to obtain such chromosomal translocations. In this way, they have managed to reproduce chromosomal translocations in human stem cells from blood and mesenchymal tissue that are identical to those observed in patients with acute myeloid leukemia (a blood and bone marrow cancer) or Ewing's sarcoma (a type of bone tumour that affects children and teenagers).

"With this breakthrough it is possible to generate cell models with the same alterations as observed in tumour cells from patients, which will allow us to study their role in tumour development," says CNIO researcher Sandra Rodríguez-Perales. "In this way, it will be possible to experimentally recapitulate the necessary subsequent steps for normal cells to transform into cancer cells."

The researchers have used the powerful RGEN tool, which was developed at the beginning of 2013, for gene manipulation in eukaryotic cells, including human ones. It is based on the design of a small RNA (RNAsg) that is complementary and specific to a 20 nucleotide DNA region. The binding of the RNAsg to the DNA acts as a signal for the Cas9 enzyme to produce a cut on the edge of the marked DNA. The system is very specific and efficient and allows for cuts to be made in the DNA's double helix wherever the researchers need to do so.

Rodríguez-Perales, Torres and Ramírez have shown that by transferring the RGEN components into primary human cells, regions of the exchanged chromosomes in some tumours can be marked, thus generating cuts in those chromosomes.

"When the DNA repair machinery tries to repair those cuts, it drives the generation of a translocation between two different chromosomes, in many cases reciprocally between the two chromosomes implicated," says CNIC researcher Raúl Torres.

The study's authors conclude by stating that the use of this technology will also allow for the clarification of how and why chromosomal translocation occurs, which without doubt will allow new anti-cancer therapeutic strategies to be tackled.


Story Source:

The above story is based on materials provided by Centro Nacional de Investigaciones Oncologicas (CNIO). Note: Materials may be edited for content and length.


Journal Reference:

  1. R. Torres, M. C. Martin, A. Garcia, Juan C. Cigudosa, J. C. Ramirez, S. Rodriguez-Perales. Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR–Cas9 system. Nature Communications, 2014; 5 DOI: 10.1038/ncomms4964

Cite This Page:

Centro Nacional de Investigaciones Oncologicas (CNIO). "Tumor chromosomal translocations reproduced for first time in human cells." ScienceDaily. ScienceDaily, 3 June 2014. <www.sciencedaily.com/releases/2014/06/140603092527.htm>.
Centro Nacional de Investigaciones Oncologicas (CNIO). (2014, June 3). Tumor chromosomal translocations reproduced for first time in human cells. ScienceDaily. Retrieved October 30, 2014 from www.sciencedaily.com/releases/2014/06/140603092527.htm
Centro Nacional de Investigaciones Oncologicas (CNIO). "Tumor chromosomal translocations reproduced for first time in human cells." ScienceDaily. www.sciencedaily.com/releases/2014/06/140603092527.htm (accessed October 30, 2014).

Share This



More Health & Medicine News

Thursday, October 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Fauci Says Ebola Risk in US "essentially Zero"

Fauci Says Ebola Risk in US "essentially Zero"

AP (Oct. 30, 2014) — NIAID Director Anthony Fauci said the risk of Ebola becoming an epidemic in the U.S. is essentially zero Thursday at the Washington Ideas Forum. He also said an Ebola vaccine will be tested in West Africa in the next few months. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Nurse Defies Ebola Quarantine With Bike Ride

Nurse Defies Ebola Quarantine With Bike Ride

AP (Oct. 30, 2014) — A nurse who vowed to defy Maine's voluntary quarantine for health care workers who treated Ebola patients followed through on her promise Thursday, leaving her home for an hour-long bike ride. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Microsoft Launches Fitness Band After Accidental Reveal

Microsoft Launches Fitness Band After Accidental Reveal

Newsy (Oct. 30, 2014) — Microsoft accidentally revealed its upcoming fitness band on Wednesday, so the company went ahead and announced it. Video provided by Newsy
Powered by NewsLook.com
Studying Effects of Music on Dementia Patients

Studying Effects of Music on Dementia Patients

AP (Oct. 30, 2014) — The University of Wisconsin-Milwaukee is studying the popular Music and Memory program to see if music, which helps improve the mood of Alzheimer's patients, can also reduce the use of prescription drugs for those suffering from dementia. (Oct. 30) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:  

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile iPhone Android Web
    Follow Facebook Twitter Google+
    Subscribe RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins